LeonaBio, Inc. (LONA)

LeonaBio Statistics

Total Valuation

LeonaBio has a market cap or net worth of $30.21 million. The enterprise value is $5.90 million.

Market Cap	30.21M
Enterprise Value	5.90M

Important Dates

The last earnings date was Friday, February 20, 2026, after market close.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

LeonaBio has 3.94 million shares outstanding. The number of shares has increased by 1.93% in one year.

Current Share Class	9.34M
Shares Outstanding	3.94M
Shares Change (YoY)	+1.93%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	42.00%
Float	6.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.13
P/TBV Ratio	1.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.70, with a Debt / Equity ratio of 0.03.

Current Ratio	9.70
Quick Ratio	9.05
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.42% and return on invested capital (ROIC) is -56.68%.

Return on Equity (ROE)	-89.42%
Return on Assets (ROA)	-42.21%
Return on Invested Capital (ROIC)	-56.68%
Return on Capital Employed (ROCE)	-144.12%
Weighted Average Cost of Capital (WACC)	18.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.54% in the last 52 weeks. The beta is 2.76, so LeonaBio's price volatility has been higher than the market average.

Beta (5Y)	2.76
52-Week Price Change	+133.54%
50-Day Moving Average	5.79
200-Day Moving Average	4.49
Relative Strength Index (RSI)	72.56
Average Volume (20 Days)	58,331

Short Selling Information

The latest short interest is 36,594, so 0.93% of the outstanding shares have been sold short.

Short Interest	36,594
Short Previous Month	31,294
Short % of Shares Out	0.93%
Short % of Float	0.58%
Short Ratio (days to cover)	0.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.27M
Pretax Income	-37.72M
Net Income	-37.72M
EBITDA	-38.30M
EBIT	-39.27M
Earnings Per Share (EPS)	-$9.66

Balance Sheet

The company has $25.23 million in cash and $912,000 in debt, with a net cash position of $24.31 million or $6.16 per share.

Cash & Cash Equivalents	25.23M
Total Debt	912,000
Net Cash	24.31M
Net Cash Per Share	$6.16
Equity (Book Value)	26.79M
Book Value Per Share	6.79
Working Capital	24.24M

Cash Flow

Operating Cash Flow	-52.35M
Capital Expenditures	n/a
Free Cash Flow	-52.35M
FCF Per Share	-$13.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LeonaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.93%
Shareholder Yield	-1.93%
Earnings Yield	-124.87%
FCF Yield	-173.27%

Analyst Forecast

The average price target for LeonaBio is $10.00, which is 30.55% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	30.55%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 18, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1